Big Pharma Bets Big on Digital Health Solutions

Pharmaceutical giants have recognised vast opportunities digital health firms bring to the table and are actively engagi...

June 9, 2022 | Thursday | Analysis
Targeting Optimal Drug Delivery

Advancements in the drug delivery systems (DDS) are gradually offering solutions to the rising prevalence of chronic con...

June 9, 2022 | Thursday | Analysis
Tetra Bio-Pharma opens new subsidiary in Australia

Canadian firm Tetra Bio-Pharma,  a leader in cannabinoid-derived drug discovery and development, has announced...

June 8, 2022 | Wednesday | News
Japan's Daiichi Sankyo to commercialise mRNA vaccine against COVID-19 in 2022

Daiichi Sankyo has announced the current progress of development of DS-5670, an mRNA vaccine, being evaluated in Japan a...

June 3, 2022 | Friday | News
Japan approves ViiV Healthcare's combination drug for HIV

ViiV Healthcare, the global specialist HIV company majority-owned by GSK with Pfizer and Shionogi as shareholders, has o...

June 2, 2022 | Thursday | News
Menarini opens regional headquarters in Dubai Science Park

Menarini, the leading Italian pharmaceutical group founded in 1886, has opened its regional headquarters in Dubai Scienc...

May 27, 2022 | Friday | News
Japan launches new treatment for chronic constipation

EA Pharma and its parent company Eisai, and Mochida Pharmaceutical have announced today that “MOVICOL HD&rdqu...

May 25, 2022 | Wednesday | News
Pharmacy-based startup SwipeRx secures $27 M to accelerate growth across Southeast Asia

SwipeRx (formerly mClinica Pharmacy Solutions), Southeast Asia's (SEA) leading platform for pharmacies, announ...

May 24, 2022 | Tuesday | News
Starpharma's nasal spray effective against influenza A & B virus

Australia-based Starpharma has announced that SPL7013, the antiviral agent in VIRALEZE nasal spray, achieved 95% and 99....

May 23, 2022 | Monday | News
VerImmune and Fosun Pharma focus on virus-inspired particle based novel immunotherapies in China

US-based  startup VerImmune and Fosun Pharma in China have entered into an exclusive license and option agreement. ...

May 23, 2022 | Monday | News
Dr. Reddy's signs multi-country deal for gastroenterology in India & select Emerging Markets

Indian firm Dr. Reddy’s Laboratories has entered into an exclusive partnership with South Korea-based HK inno.N Co...

May 19, 2022 | Thursday | News
Kyowa Kirin to build new biopharma API building

Japanese firm Kyowa Kirin has decided to build a new active pharmaceutical ingredient (API) manufacturing building (HB7 ...

May 20, 2022 | Friday | News
Vetter Achieves a Three-Peat in Winning the Best Managed Companies Award

Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family (second from left) along with ...

May 18, 2022 | Wednesday | News
UK-based Croda announces new pharma business

UK-based Croda has announced that its Health Care division will now become Croda Pharma, bringing its core speciality ex...

May 18, 2022 | Wednesday | News
US FDA approves Lilly's COVID-19 drug

Eli Lilly and Company and Incyte have announced that the U.S. Food and Drug Administration (FDA) has approved OLUMIANT&n...

May 16, 2022 | Monday | News
Novo Holdings, Shionogi offer treatment for invasive fungal infections in Europe and Asia

Novo Holdings has announced that its portfolio company F2G has entered into a strategic collaboration with Japan-based S...

May 16, 2022 | Monday | News
WODA combining forces to reach patients with rare diseases across globe

EffRx Pharmaceuticals, Medis, Orpharm, OrphanDC, and Vector Pharma, announced the newly formed World Orphan Drug Allianc...

May 13, 2022 | Friday | News
Taiwan strengthens treatment offering for inflammation and pain after cataract surgery

Taiwan-based Formosa Pharmaceuticals and AimMax Therapeutics have reported successful top-line results from CPN-301, the...

May 13, 2022 | Friday | News
Aravax appoints Dr Brett Haumann to Board of Directors

Australia's Aravax, a clinical stage biotechnology company focused on developing the most advanced novel therapy for pea...

May 11, 2022 | Wednesday | News
Immuron appoints Steven Lydeamore as Chief Executive Officer

Immuron Limited, an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeuti...

May 6, 2022 | Friday | News
Orion partners with Jemincare for novel non-opioid drug candidate for pain treatment

Finland's Orion Corporation has entered into an agreement with Chinese Jemincare, through which Orion will receive exclu...

May 6, 2022 | Friday | News
5 Transformative Merits of Blockchain in Pharma

Blockchain - an open, decentralised, secure, public ledger and the technology behind crypto currencies like bitcoin and ...

May 6, 2022 | Friday | Analysis
EyePoint Pharma with Betta Pharma lay focus on eye diseases across the globe

EyePoint Pharmaceuticals has announced the execution of a license agreement with Betta Pharmaceuticals to develop and co...

May 5, 2022 | Thursday | News
Jazz Pharma and Sumitomo Pharma to develop therapies for sleep disorders

Ireland-based Jazz Pharmaceuticals and Sumitomo Pharma Co. in Japan, have entered into an exclusive licensing agree...

May 5, 2022 | Thursday | News
NiKang Therapeutics, Hansoh Pharma ink $200M worth deal for cancer treatment in Greater China

NiKang Therapeutics , a clinical stage biotech company focused on developing innovative small molecule oncology medicine...

May 4, 2022 | Wednesday | News